...
首页> 外文期刊>International Journal of Clinical and Experimental Pathology >Acute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literature
【24h】

Acute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literature

机译:急性早幼粒细胞白血病在异染色质17上隐含t(15; 17):一例病例报告并文献复习

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Acute Promyelocytic Leukemia (APL) is one of the most curable leukemia which shows great sensitivity to all-trans retinoic acid (ATRA) although a small number of the patients present poor prognosis and short survival. Isochromosome 17 in APL which usually bears an additional copy of RARA/PML fusion gene is considered to be a negative factor on its prognosis. Cryptic t(15;17) on i(17q) leads to an extra copy of PML/RARA rather than RARA/PML which may confer a worse prognosis. We describe here a rare APL case with complex chromosomal abnormality including isochromosome 17 bearing cryptic t(15;17) showing poor outcome. The patient lacks a classic t(15;17) and fluorescence in situ hybridization (FISH) presents 2 PML/RARA fusion signals on both long arms of the isochromosome. The patient also acquired a secondary mutation at relapse when the initial karyotype was already a complex karyotype involving chromosome 13, 17 and 22 at the same time. The poor response of this patient to traditional chemotherapy like ATRA and novel therapy like arsenic trioxide (ATO) suggests that early auto-hematological stem cell transplantation may be the choice of APL with isochromosome 17 especially with cryptic t(15;17) on i(17q). We are the first to show a clear history and evidence of FISH of these kind of cases. A small summary of cases with cryptic t(15;17) on isochromosome 17 is also made.
机译:急性早幼粒细胞白血病(APL)是最可治愈的白血病之一,对全反式维甲酸(ATRA)表现出很高的敏感性,尽管少数患者预后差且生存期短。通常带有一个额外拷贝的RARA / PML融合基因的APL中的等染色体17被认为是其预后的负面因素。 i(17q)上的隐式t(15; 17)导致了额外的PML / RARA副本,而不是RARA / PML,这可能会使预后恶化。我们在这里描述了一个罕见的APL病例,它具有复杂的染色体异常,包括带有隐性t(15; 17)的等染色体17,显示不良结果。该患者缺乏经典的t(15; 17),荧光原位杂交(FISH)在同染色体的两个长臂上均显示2个PML / RARA融合信号。当初始核型已经是同时包含13号,17号和22号染色体的复杂核型时,患者在复发时也获得了二次突变。该患者对传统化学疗法(如ATRA)和新型疗法(如三氧化二砷(ATO))的反应较差,这表明早期的自体血液干细胞移植可能是等位基因17特别是i(i)隐性t(15; 17)的APL选择。 17q)。我们是第一个对此类病例显示清晰的FISH历史和证据的医院。还对异染色质17上隐含t(15; 17)的病例进行了简短总结。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号